Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase
- PMID: 10588735
- PMCID: PMC24466
- DOI: 10.1073/pnas.96.25.14505
Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase
Abstract
The Sanfilippo syndrome type B is an autosomal recessive disorder caused by mutation in the gene (NAGLU) encoding alpha-N-acetylglucosaminidase, a lysosomal enzyme required for the stepwise degradation of heparan sulfate. The most serious manifestations are profound mental retardation, intractable behavior problems, and death in the second decade. To generate a model for studies of pathophysiology and of potential therapy, we disrupted exon 6 of Naglu, the homologous mouse gene. Naglu-/- mice were healthy and fertile while young and could survive for 8-12 mo. They were totally deficient in alpha-N-acetylglucosaminidase and had massive accumulation of heparan sulfate in liver and kidney as well as secondary changes in activity of several other lysosomal enzymes in liver and brain and elevation of gangliosides G(M2) and G(M3) in brain. Vacuolation was seen in many cells, including macrophages, epithelial cells, and neurons, and became more prominent with age. Although most vacuoles contained finely granular material characteristic of glycosaminoglycan accumulation, large pleiomorphic inclusions were seen in some neurons and pericytes in the brain. Abnormal hypoactive behavior was manifested by 4.5-mo-old Naglu-/- mice in an open field test; the hyperactivity that is characteristic of affected children was not observed even in younger mice. In a Pavlovian fear conditioning test, the 4.5-mo-old mutant mice showed normal response to context, indicating intact hippocampal-dependent learning, but reduced response to a conditioning tone, perhaps attributable to hearing impairment. The phenotype of the alpha-N-acetylglucosaminidase-deficient mice is sufficiently similar to that of patients with the Sanfilippo syndrome type B to make these mice a good model for study of pathophysiology and for development of therapy.
Figures






Similar articles
-
Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.J Neurosci. 2004 Nov 10;24(45):10229-39. doi: 10.1523/JNEUROSCI.3558-04.2004. J Neurosci. 2004. PMID: 15537895 Free PMC article.
-
Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B.Mol Genet Metab. 2000 Dec;71(4):573-80. doi: 10.1006/mgme.2000.3095. Mol Genet Metab. 2000. PMID: 11136549
-
Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.Comp Med. 2003 Dec;53(6):622-32. Comp Med. 2003. PMID: 14727810
-
Glycosaminoglycans and mucopolysaccharidosis type III.Front Biosci (Landmark Ed). 2016 Jun 1;21(7):1393-409. doi: 10.2741/4463. Front Biosci (Landmark Ed). 2016. PMID: 27100513 Review.
-
Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.Hum Mutat. 2001 Oct;18(4):264-81. doi: 10.1002/humu.1189. Hum Mutat. 2001. PMID: 11668611 Review.
Cited by
-
Novel pathologic findings associated with urinary retention in a mouse model of mucopolysaccharidosis type IIIB.Comp Med. 2009 Apr;59(2):139-46. Comp Med. 2009. PMID: 19389305 Free PMC article.
-
Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C.Rare Dis. 2015 May 21;3(1):e1049793. doi: 10.1080/21675511.2015.1049793. eCollection 2015. Rare Dis. 2015. PMID: 26459666 Free PMC article.
-
Heterologous HSPC Transplantation Rescues Neuroinflammation and Ameliorates Peripheral Manifestations in the Mouse Model of Lysosomal Transmembrane Enzyme Deficiency, MPS IIIC.Cells. 2024 May 20;13(10):877. doi: 10.3390/cells13100877. Cells. 2024. PMID: 38786099 Free PMC article.
-
Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy.Mol Genet Metab. 2008 Nov;95(3):142-51. doi: 10.1016/j.ymgme.2008.07.003. Epub 2008 Aug 15. Mol Genet Metab. 2008. PMID: 18707908 Free PMC article.
-
Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.Exp Cell Res. 2021 Oct 1;407(1):112785. doi: 10.1016/j.yexcr.2021.112785. Epub 2021 Aug 16. Exp Cell Res. 2021. PMID: 34411609 Free PMC article.
References
-
- Neufeld E F, Muenzer J. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver C R, Beaudet A L, Sly W S, Valle D, editors. New York: McGraw–Hill; 1995. pp. 2465–2494.
-
- Weber B, Blanch L, Clements P R, Scott H S, Hopwood J J. Hum Mol Genet. 1996;5:771–777. - PubMed
-
- Zhao Z, Yazdani A, Shen Y, Sun Z, Bailey J, Caskey C T, Lee C C. Mamm Genome. 1996;7:686–690. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases